This inventor holds 1 USPTO granted patent. Top assignee: Gifu University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Aya Shibata: Innovator in Oligonucleotide Derivatives
Introduction
Aya Shibata is a prominent inventor based in Gifu, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide derivatives. Her innovative work focuses on enhancing drug delivery systems through the use of these derivatives.
Latest Patents
Aya Shibata holds a patent for an "Oligonucleotide derivative, oligonucleotide construct using the same, and methods for producing them." This invention is represented by a specific formula and is designed to facilitate the introduction of oligonucleotides into cells. The oligonucleotide derivative is characterized by its ability to bind to ligands on cell surfaces, enabling selective drug delivery. Notably, this derivative can be synthesized and introduced into cells without the need for lipofection reagents. The components of the oligonucleotide include modified or unmodified oligonucleotides, sugar substituents, peptide chains, or tocopherol-binding groups.
Career Highlights
Aya Shibata is affiliated with Gifu University, where she conducts her research and development activities. Her work has garnered attention for its potential applications in medical and pharmaceutical fields. With a focus on innovative solutions, she continues to push the boundaries of biotechnology.
Collaborations
Aya collaborates with Yukio Kitade, who is also involved in research related to oligonucleotide derivatives. Their partnership enhances the scope and impact of their work in the field.
Conclusion
Aya Shibata is a trailblazer in the development of oligonucleotide derivatives, with a patent that showcases her innovative approach to drug delivery. Her contributions to biotechnology are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
